ArticleExperimental & molecular medicine2011

Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.

Myung Hee Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.